Kite Pharma, Inc. has expanded its agreement with Tel Aviv Sourasky Medical Center to research and develop novel approaches to CAR T cell therapy in cancer immunotherapy. Kite will collaborate with Professor Zelig Eshhar, Ph.D., the leading pioneer in CAR T cell research and chair of Immunology Research.   “Zelig’s award-winning research has been at the center of CAR T cell programs currently advancing in clinical studies. We are pleased to have an expanded agreement with Zelig and t...